Comprehensive Yoga Program (SKY) as Adjunct Therapy for Prostate Cancer

Status Active, not recruiting

Clinical Trial Summary

This randomized pilot trial studies the effect of comprehensive yoga program (SKY) in reducing stress, pain, and fatigue, and improving psychological well-being in patients with prostate cancer. SKY is one of the most widely used breathing techniques derived from yoga. SKY Yoga may improve quality of life in patients with prostate cancer.

Clinical Trial Description

PRIMARY OBJECTIVES: I. Determine any change in pain, fatigue and psychological well-being as a result of SKY in prostate cancer (PCa) patients. II. Assess changes in some physiological parameters in response to SKY in the same subjects, compare these with those from Part 1, and assess whether these translate into clinical effects. OUTLINE: Patients are randomized to 1 of 2 arms. ARM I (Control Group): Patients undergo collection of blood, saliva, and hair samples after signing consent (pre-test 1), within 6-8 weeks after pre-test 1 (post-test 1), and within 2-4 months after post-test 1 (post-test 2). Patients may receive yoga instruction for 1 week after post-test 2. ARM II (Yoga Group): Patients receive yoga instruction over approximately 3 hours daily for 5 days of week 1 and over 2 hours once a week of weeks 2-13. Patients also undergo collection of blood, saliva, and hair samples within 2 months prior to starting yoga instruction, within weeks 2-3, and within weeks 14-15. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03220945
Study type	Interventional
Source	Emory University
Contact
Status	Active, not recruiting
Phase	N/A
Start date	January 6, 2016
Completion date	January 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04457232` - Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation	Phase 1
Active, not recruiting	`NCT03661437` - Systemic Light Exposure in Preventing Frailty in Older Patients With Prostate Cancer on Hormonal Therapy	Early Phase 1
Completed	`NCT02337465` - KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic Cancer	N/A
Completed	`NCT03013413` - Ultrasound-Based Imaging Using the Aixplorer System in Diagnosing Prostate Cancer in Patients Undergoing Biopsy	N/A
Recruiting	`NCT06037863` - Evaluation of the Impact of Empty Versus Full Bladder in Patients With Prostate Cancer, RELIEF Trial	N/A
Active, not recruiting	`NCT03580499` - Vitamin B6 in Reducing Hot Flashes in Participants With Prostate Cancer Undergoing Antiandrogen Therapy	N/A
Completed	`NCT03326440` - Virtual Environment Radiotherapy to Improve Patients' Compliance to Radiotherapy (RT) in Prostate Cancer	N/A
Recruiting	`NCT04597359` - To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring	Phase 2
Active, not recruiting	`NCT03263650` - Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC	Phase 2
Active, not recruiting	`NCT04600336` - Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer	Phase 2
Active, not recruiting	`NCT04299620` - Micro-Ultrasound for the Detection and Localization of Prostate Cancer Tumors in Patients Undergoing Radical Prostatectomy	N/A
Completed	`NCT04976257` - Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion	Early Phase 1
Completed	`NCT02957981` - The Genetic Education for Men Trial: Web-Based Education vs. Standard Care	N/A
Withdrawn	`NCT03408561` - Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer	N/A
Enrolling by invitation	`NCT06347809` - DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine
Enrolling by invitation	`NCT04254133` - Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study
Recruiting	`NCT05519878` - Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers	N/A
Recruiting	`NCT02994758` - Development of Diagnostics and Treatment of Urological Cancers	N/A
Completed	`NCT01497431` - Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants	Phase 1
Active, not recruiting	`NCT00002540` - Screening for Prostate Cancer in Older Patients (PLCO Screening Trial)	N/A